How to debottleneck antibody development pipelines

Regeneron, cell culture, high-throughput, antibody

Would you like to debottleneck your antibody development pipelines in order to increase your throughput of new product opportunities?

Dr Kevin Bailey, VP Preclinical Manufacturing and Process Development at Regeneron spoke earlier this year at the Cell Culture World Congress highlighting how the growth of the biopharmaceutical space is driven by product innovation and high-throughput strategies when it comes to new target identification and getting POCs to patients quickly.

During the presentation Kevin also posed the question, "Is true process optimization best carried out ‘off the critical path'?"

DOWNLOAD the presentation slides now to find out the details!

Leave a Reply

Your email address will not be published. Required fields are marked *